These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M, Zhang XY, Yu X. Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [Abstract] [Full Text] [Related]
4. A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion. Mo M, Liu S, Ma X, Tan C, Wei L, Sheng Y, Song Y, Zeng X, Huang D, Qiu X. J Cancer Res Clin Oncol; 2019 Aug; 145(8):2027-2038. PubMed ID: 31243545 [Abstract] [Full Text] [Related]
5. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721. Liu RT, Cao JL, Yan CQ, Wang Y, An CJ, Lv HT. Biosci Rep; 2017 Apr 30; 37(2):. PubMed ID: 28143959 [Abstract] [Full Text] [Related]
6. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis. Wang H, Ke J, Guo Q, Barnabo Nampoukime KP, Yang P, Ma K. J Cell Mol Med; 2018 Dec 30; 22(12):5862-5876. PubMed ID: 30246921 [Abstract] [Full Text] [Related]
7. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma. Zhou Q, Zhang W, Wang Z, Liu S. BMC Cancer; 2019 Jul 24; 19(1):731. PubMed ID: 31340767 [Abstract] [Full Text] [Related]
8. LINC00339 regulates ROCK1 by miR-152 to promote cell proliferation and migration in hepatocellular carcinoma. Chen K, Zhang L. J Cell Biochem; 2019 Sep 24; 120(9):14431-14443. PubMed ID: 31081143 [Abstract] [Full Text] [Related]
10. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression. Hu B, Cai H, Zheng R, Yang S, Zhou Z, Tu J. Int J Biochem Cell Biol; 2017 Nov 24; 92():34-42. PubMed ID: 28919047 [Abstract] [Full Text] [Related]
12. The long non-coding RNA AK001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma. Han QL, Chen BT, Zhang KJ, Xia ST, Zhong WW, Zhao ZM. Eur Rev Med Pharmacol Sci; 2019 Mar 24; 23(5):2013-2019. PubMed ID: 30915744 [Abstract] [Full Text] [Related]
13. LncRNA MINCR promotes the development of liver cancer by regulating microRNA-107/β-catenin. Li H, Yuan R, Wang H, Li C, Wei J. J BUON; 2020 Mar 24; 25(2):972-980. PubMed ID: 32521894 [Abstract] [Full Text] [Related]
14. Overexpression of long non-coding RNA MINCR contributes to progressive clinicopathological features and poor prognosis of human hepatocellular carcinoma. Jin XL, Lian JR, Guan YH. Eur Rev Med Pharmacol Sci; 2018 Dec 24; 22(23):8197-8202. PubMed ID: 30556858 [Abstract] [Full Text] [Related]
16. The long non-coding RNA MALAT1 promotes the migration and invasion of hepatocellular carcinoma by sponging miR-204 and releasing SIRT1. Hou Z, Xu X, Zhou L, Fu X, Tao S, Zhou J, Tan D, Liu S. Tumour Biol; 2017 Jul 24; 39(7):1010428317718135. PubMed ID: 28720061 [Abstract] [Full Text] [Related]
17. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression. Gao W, Chen X, Chi W, Xue M. Int J Mol Med; 2020 Nov 24; 46(5):1743-1754. PubMed ID: 33000222 [Abstract] [Full Text] [Related]
19. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Wang F, Xie C, Zhao W, Deng Z, Yang H, Fang Q. Clin Exp Med; 2017 Feb 24; 17(1):33-43. PubMed ID: 26433964 [Abstract] [Full Text] [Related]
20. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression. Yan S, Tang Z, Chen K, Liu Y, Yu G, Chen Q, Dang H, Chen F, Ling J, Zhu L, Huang A, Tang H. J Exp Clin Cancer Res; 2018 Sep 03; 37(1):214. PubMed ID: 30176933 [Abstract] [Full Text] [Related] Page: [Next] [New Search]